MoneyWorks4Me

Neuland Laboratories informs about details of loss of certificate

09 Oct 2024 Evaluate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that the following shareholder(s) has reported to the Company about the loss of his/her share certificate(s) and has requested for issue of ‘Letter of Confirmation’ in lieu of physical share certificate(s): Name of the shareholder: PN Suresh; Folio No. 0008744. The particulars relating to the loss of share certificate(s) are enclosed.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

23380.00 157.85 (0.68%)
14-Aug-2026 15:32 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: